DK1257553T3 - Pyrrolopyrimidinonderivater, fremgangsmåder til fremstilling og anvendelse - Google Patents
Pyrrolopyrimidinonderivater, fremgangsmåder til fremstilling og anvendelseInfo
- Publication number
- DK1257553T3 DK1257553T3 DK01908397T DK01908397T DK1257553T3 DK 1257553 T3 DK1257553 T3 DK 1257553T3 DK 01908397 T DK01908397 T DK 01908397T DK 01908397 T DK01908397 T DK 01908397T DK 1257553 T3 DK1257553 T3 DK 1257553T3
- Authority
- DK
- Denmark
- Prior art keywords
- sub
- sup
- cycloalkyl
- optionally substituted
- fluoro atoms
- Prior art date
Links
- DXVAQZJPPDWTNY-UHFFFAOYSA-N pyrrolo[3,2-d]pyrimidin-2-one Chemical class O=C1N=CC2=NC=CC2=N1 DXVAQZJPPDWTNY-UHFFFAOYSA-N 0.000 title abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 7
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 125000001153 fluoro group Chemical group F* 0.000 abstract 5
- 125000003342 alkenyl group Chemical group 0.000 abstract 3
- 125000000304 alkynyl group Chemical group 0.000 abstract 3
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Ophthalmology & Optometry (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Pregnancy & Childbirth (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Otolaryngology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20000007625A KR100358083B1 (ko) | 2000-02-17 | 2000-02-17 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1257553T3 true DK1257553T3 (da) | 2004-10-04 |
Family
ID=19647449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK01908397T DK1257553T3 (da) | 2000-02-17 | 2001-02-15 | Pyrrolopyrimidinonderivater, fremgangsmåder til fremstilling og anvendelse |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6962911B2 (fr) |
| EP (1) | EP1257553B1 (fr) |
| JP (1) | JP4845076B2 (fr) |
| KR (1) | KR100358083B1 (fr) |
| CN (1) | CN1312153C (fr) |
| AT (1) | ATE267829T1 (fr) |
| AU (2) | AU3614001A (fr) |
| BR (1) | BRPI0108395B8 (fr) |
| CA (1) | CA2400268C (fr) |
| DE (1) | DE60103508T2 (fr) |
| DK (1) | DK1257553T3 (fr) |
| ES (1) | ES2222344T3 (fr) |
| HU (1) | HU230344B1 (fr) |
| IL (2) | IL151234A0 (fr) |
| MX (1) | MXPA02007942A (fr) |
| NO (1) | NO323553B1 (fr) |
| NZ (1) | NZ520842A (fr) |
| PL (1) | PL210796B1 (fr) |
| PT (1) | PT1257553E (fr) |
| RU (1) | RU2263676C2 (fr) |
| TR (1) | TR200402101T4 (fr) |
| WO (1) | WO2001060825A1 (fr) |
| ZA (1) | ZA200206587B (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100358083B1 (ko) * | 2000-02-17 | 2002-10-25 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
| EP1362858A1 (fr) * | 2002-05-15 | 2003-11-19 | SK Chemicals Co., Ltd. | Dérivés de pyrrolopyrimidine, procédé de préparation et leur utilisation |
| DE10229778A1 (de) * | 2002-07-03 | 2004-01-29 | Bayer Ag | Neue Verwendung von Imidazotriazinonen |
| FR2842809A1 (fr) * | 2002-07-26 | 2004-01-30 | Greenpharma Sas | NOUVELLES PYRAZOLO[1,5-a]-1,3,5-TRIAZINES SUBSTITUEES ET LEURS ANALOGUES, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, UTILISATION A TITRE DE MEDICAMENT ET PROCEDES POUR LEUR PREPARATION |
| CN100374441C (zh) | 2003-06-06 | 2008-03-12 | 天津倍方科技发展有限公司 | 二氢吡咯[2，3-d]嘧啶-4-酮衍生物，其制备方法及其制药用途 |
| TW200745106A (en) * | 2005-10-03 | 2007-12-16 | Astrazeneca Ab | Chemical compounds |
| KR20080003599A (ko) * | 2006-07-03 | 2008-01-08 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체의 겐티세이트 염 및 이의제조방법 |
| EP2038282B1 (fr) * | 2006-07-03 | 2016-12-21 | SK Chemicals, Co., Ltd. | Sels de dérivés de pyrrolopyrimidinone et méthode d'obtention |
| KR101002490B1 (ko) * | 2007-06-09 | 2010-12-17 | 동아제약주식회사 | 유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물 |
| DK2488532T3 (en) | 2009-10-16 | 2018-08-13 | Melinta Therapeutics Inc | ANTIMICROBIAL COMPOUNDS AND PROCEDURES FOR PREPARING AND USING THE SAME |
| EA023350B1 (ru) | 2009-10-16 | 2016-05-31 | Мелинта Терапьютикс, Инк. | Противомикробные соединения, способы их получения и применение |
| EP2488525B1 (fr) | 2009-10-16 | 2018-04-25 | Melinta Therapeutics, Inc. | Composés anti-microbiens et procédés permettant de fabriquer et d'utiliser ces composés |
| JP2013523809A (ja) | 2010-04-05 | 2013-06-17 | エスケー ケミカルズ カンパニー リミテッド | Ｐｄｅ５抑制剤を含む皮膚しわ改善用組成物 |
| CN102372730B (zh) * | 2010-08-19 | 2014-03-26 | 山东轩竹医药科技有限公司 | 桥环取代的磷酸二酯酶抑制剂 |
| CN102134242B (zh) * | 2011-01-21 | 2013-08-28 | 浙江大德药业集团有限公司 | 一种用于治疗阳痿的快速长效的化合物 |
| TWI490220B (zh) * | 2011-04-04 | 2015-07-01 | Sk Chemicals Co Ltd | 包含ｐｄｅ５抑制劑之用於減少皮膚皺紋之組成物 |
| SG194489A1 (en) * | 2011-04-15 | 2013-12-30 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| EP2753332B1 (fr) | 2011-09-09 | 2017-02-15 | SK Chemicals Co., Ltd. | Mirodenafil destinée à atténuer les rides cutanées |
| KR102146673B1 (ko) | 2012-12-04 | 2020-08-21 | 주식회사 아리바이오 | 포스포디에스테라제 타입 ５ 저해제를 포함하는 신경세포의 아폽토시스 억제용 조성물 |
| EP3038623A4 (fr) | 2013-09-09 | 2017-04-19 | Melinta Therapeutics, Inc. | Composés antimicrobiens et procédés de fabrication et méthodes d'utilisation de ceux-ci |
| JP2016536338A (ja) | 2013-09-09 | 2016-11-24 | メリンタ セラピューティクス，インコーポレイテッド | 抗微生物化合物ならびにそれの製造方法および使用方法 |
| SG11201707346RA (en) | 2015-03-11 | 2017-10-30 | Melinta Therapeutics Inc | Antimicrobial compounds and methods of making and using the same |
| CN104744478B (zh) * | 2015-03-20 | 2016-08-24 | 中国人民解放军第二军医大学 | 一种防治辐射损伤的化合物、单晶及其制备方法和应用 |
| ES2912648T3 (es) * | 2015-11-16 | 2022-05-26 | Topadur Pharma Ag | Derivados de 2-fenil-3,4-dihidropirrolo[2,1-f] [1,2,4]triazinona como inhibidores de la fosfodiesterasa y usos de los mismos |
| WO2017193016A1 (fr) | 2016-05-06 | 2017-11-09 | Melinta Therapeutics, Inc. | Antimicrobiens et leurs procédés de préparation et d'utilisation |
| KR102670626B1 (ko) * | 2017-05-22 | 2024-05-29 | 토파두르 파마 아게 | 가용성 구아닐레이트 사이클라제 활성제 및 포스포디에스테라제 억제제의 신규한 이중 작용 방식 및 이의 용도 |
| KR102836746B1 (ko) | 2018-08-06 | 2025-07-21 | 니콕스 에스아 | 산화질소 방출 포스포디에스테라제 타입 5 억제제 |
| US20220031704A1 (en) | 2018-11-28 | 2022-02-03 | Topadur Pharma Ag | Novel dual mode of action soluble guanylate cyclase activators and phosphodiesterase inhibitors and uses thereof |
| KR102271305B1 (ko) | 2020-05-21 | 2021-06-30 | 주식회사 아리바이오 | 치매 예방 및 치료용 조성물 |
| WO2021245192A1 (fr) | 2020-06-04 | 2021-12-09 | Topadur Pharma Ag | Nouveaux activateurs de la guanylate cyclase soluble à double mode d'action et inhibiteurs de phosphodiestérase et leurs utilisations |
| CN111825593B (zh) * | 2020-08-19 | 2023-04-07 | 上海成澄科技有限公司 | 3-氨基吡咯-2-甲酰胺类化合物的合成方法 |
| KR102272907B1 (ko) | 2020-11-05 | 2021-07-05 | 주식회사 아리바이오 | 치매 예방 및 치료용 조성물 |
| KR102272910B1 (ko) | 2021-01-28 | 2021-07-06 | 주식회사 아리바이오 | 당뇨병을 동반한 치매 예방 및 치료용 조성물 |
| KR20220140960A (ko) | 2021-04-12 | 2022-10-19 | 주식회사 아리바이오 | 당뇨병을 동반한 치매 예방 및 치료용 조성물 |
| KR102311224B1 (ko) | 2021-04-23 | 2021-10-13 | 주식회사 아리바이오 | Pde5 억제제와 글루코코르티코이드 수용체 길항제 병용투여를 통한 치매 예방 및 치료용 조성물 |
| KR20220146095A (ko) | 2021-04-23 | 2022-11-01 | 주식회사 아리바이오 | Pde5 억제제와 글루코코르티코이드 수용체 길항제 병용투여를 통한 치매 예방 및 치료용 조성물 |
| CA3228160A1 (fr) | 2021-09-29 | 2023-04-06 | Topadur Pharma Ag | Compositions topiques de derives de 2-phenyl-3,4-dihydropyrrolo[2,l-f][1,2,4]triazinone et leurs utilisations |
| KR20230129639A (ko) | 2022-03-02 | 2023-09-11 | 연세대학교 산학협력단 | 이중작용 pde5 억제제/질산유기에스터의 국소 혈류 증진을 위한 경피 투약 형태 |
| US20250161309A1 (en) | 2022-03-02 | 2025-05-22 | Topadur Pharma Ag | Topical compositions and uses therof |
| KR20240117491A (ko) | 2023-01-25 | 2024-08-01 | 주식회사 아리바이오 | 포스포디에스테라제 타입 ５ 저해제를 유효성분으로 포함하는 외상 후 스트레스 장애의 예방 또는 치료용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5761734B2 (fr) * | 1973-09-27 | 1982-12-25 | Takeda Chemical Industries Ltd | |
| JPS5761734A (en) * | 1980-10-02 | 1982-04-14 | Teijin Ltd | Spun like fabric |
| GB9013750D0 (en) * | 1990-06-20 | 1990-08-08 | Pfizer Ltd | Therapeutic agents |
| US5236926A (en) * | 1992-02-03 | 1993-08-17 | Warner-Lambert Company | 9-substituted-8-halo or -8-hydroxy-9-deazaguanines as inhibitors or PNP for pharmaceutical compositions |
| GB9311920D0 (en) * | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
| JP3713783B2 (ja) * | 1995-01-20 | 2005-11-09 | 大正製薬株式会社 | １Ｈ−ピラゾロ［３，４−ｄ］ピリミジン−４−オン誘導体 |
| RU2097394C1 (ru) * | 1996-02-06 | 1997-11-27 | Открытое акционерное общество "Акрон" | Пресс-масса для изготовления древесно-стружечных плит |
| PL336586A1 (en) * | 1997-04-25 | 2000-07-03 | Pfizer | Pyrazoylpyrimidinones inhibiting the cyclic guanosine 3',5'-monophosphate phosphodiesterase of type 5 (cgmp pde5) for treating sexual disorders |
| JP3721077B2 (ja) * | 1998-04-20 | 2005-11-30 | ファイザー・インク | 性的不全を治療するためのピラゾロピリミジノンｃＧＭＰＰＤＥ５阻害剤 |
| KR100358083B1 (ko) * | 2000-02-17 | 2002-10-25 | 에스케이케미칼주식회사 | 피롤로피리미디논 유도체와 이의 제조방법, 그리고 이의용도 |
-
2000
- 2000-02-17 KR KR20000007625A patent/KR100358083B1/ko not_active Expired - Lifetime
-
2001
- 2001-02-15 WO PCT/KR2001/000227 patent/WO2001060825A1/fr not_active Ceased
- 2001-02-15 IL IL15123401A patent/IL151234A0/xx unknown
- 2001-02-15 US US10/204,327 patent/US6962911B2/en not_active Expired - Lifetime
- 2001-02-15 HU HU0300527A patent/HU230344B1/hu unknown
- 2001-02-15 AU AU3614001A patent/AU3614001A/xx active Pending
- 2001-02-15 RU RU2002124872/04A patent/RU2263676C2/ru active
- 2001-02-15 DE DE60103508T patent/DE60103508T2/de not_active Expired - Lifetime
- 2001-02-15 ES ES01908397T patent/ES2222344T3/es not_active Expired - Lifetime
- 2001-02-15 BR BRPI0108395A patent/BRPI0108395B8/pt not_active IP Right Cessation
- 2001-02-15 JP JP2001560209A patent/JP4845076B2/ja not_active Expired - Lifetime
- 2001-02-15 PT PT01908397T patent/PT1257553E/pt unknown
- 2001-02-15 AU AU2001236140A patent/AU2001236140B9/en not_active Expired
- 2001-02-15 CA CA002400268A patent/CA2400268C/fr not_active Expired - Lifetime
- 2001-02-15 MX MXPA02007942A patent/MXPA02007942A/es active IP Right Grant
- 2001-02-15 NZ NZ520842A patent/NZ520842A/en not_active IP Right Cessation
- 2001-02-15 PL PL358188A patent/PL210796B1/pl unknown
- 2001-02-15 EP EP01908397A patent/EP1257553B1/fr not_active Expired - Lifetime
- 2001-02-15 AT AT01908397T patent/ATE267829T1/de active
- 2001-02-15 TR TR2004/02101T patent/TR200402101T4/xx unknown
- 2001-02-15 DK DK01908397T patent/DK1257553T3/da active
- 2001-02-15 CN CNB018075002A patent/CN1312153C/zh not_active Expired - Lifetime
-
2002
- 2002-08-13 IL IL151234A patent/IL151234A/en active IP Right Grant
- 2002-08-13 NO NO20023823A patent/NO323553B1/no not_active IP Right Cessation
- 2002-08-16 ZA ZA200206587A patent/ZA200206587B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1257553T3 (da) | Pyrrolopyrimidinonderivater, fremgangsmåder til fremstilling og anvendelse | |
| CY1108269T1 (el) | Παραγωγα της αβερμεκτινης β1 που εχουν εναν αμινοσουλφονυλοξυ υποκαταστατη στη θεση 4" | |
| DK1622879T3 (da) | Pyrimidinforbindelser og skadedyrsbekæmpelsespræparater indeholdende disse | |
| BG104248A (en) | Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides | |
| NO20031001L (no) | Polyarylkarboksamider nyttige som lipidsenkende midler | |
| WO2001077107A8 (fr) | Production et utilisation de composes heterocycliques | |
| ATE302775T1 (de) | Carbolinderivate | |
| SE0000540D0 (sv) | New compounds | |
| HRP20020938B1 (en) | Tropane derivatives useful in therapy | |
| DK0794949T3 (da) | Hidtil ukendte 3,5-dioxo-(2H,4H)-1,2,4-triazinderivater, fremstilling heraf og deres anvendelse som lægemidler | |
| DE50204803D1 (en) | 4-alkylsubstituierte thienyloxy-pyrididne als herbizide | |
| DK0869946T3 (da) | Phenylimidazolidiner og deres anvendelse som anti-androgent middel | |
| DK1414302T3 (da) | 7-aminotriazolopyrimidiner til bekæmpelse af skadelige svampe | |
| HRP20090162T1 (en) | Quinolinone-carboxamide compounds as 5-ht4 receptor agonists | |
| ATE346067T1 (de) | Carbolinderivate | |
| DK0862562T3 (da) | Benzoxazepinforbindelser, fremstilling deraf og anvendelse deraf som lipidniveauformindskende midler | |
| TW200640916A (en) | (1,5-diphenyl-1H-pyrazol-3-yl)oxadiazole derivatives, their preparation and their application in therapeutics | |
| ATE135348T1 (de) | Pyrimidin-4-carboxamidderivate, ihre herstellung und ihre verwendung in der therapie | |
| IS6174A (is) | Nýjar afleiður og hliðstæður af galantamíni | |
| NO20035774L (no) | Substituerte benzopyranderivater mot arytmier | |
| ATE550332T1 (de) | 4-imidazolin-2-onverbindungen als p38-map- kinaseinhibitors | |
| PA8607801A1 (es) | Compuestos | |
| DE60112960D1 (de) | Kondensierte pyridoindolderivate | |
| ATE333457T1 (de) | Zyklische gmp-spezifische phosphodiesteraseinhibitoren | |
| DK0544587T3 (da) | Hidtil ukendte alpha-methylen-2-vinylbenzeneddikesyrederivater, fremgangsmåde til deres fremstilling og deres anvendelse som pesticider |